Home/Filings/4/0000950170-25-105255
4//SEC Filing

Baranick Brian 4

Accession 0000950170-25-105255

CIK 0001124140other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 5:30 PM ET

Size

31.3 KB

Accession

0000950170-25-105255

Insider Transaction Report

Form 4
Period: 2025-08-05
Baranick Brian
EVP, GM, Precision Oncology
Transactions
  • Tax Payment

    Common Stock

    2025-08-05$46.83/sh2,717$127,23725,226 total
  • Exercise/Conversion

    Common Stock

    2025-08-05+5,35027,943 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-055,35016,051 total
    Common Stock (5,350 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    670
Footnotes (5)
  • [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
  • [F2]Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
  • [F3]In addition to the shares of Common Stock reported on this Form 4, which total 25,896 shares, Mr. Baranick also holds, in the aggregate, an additional 73,080 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F5]Represents a restricted stock unit award granted on August 5, 2024 that partially vested on August 5, 2025. The restricted stock units vest in four equal annual installments.

Issuer

EXACT SCIENCES CORP

CIK 0001124140

Entity typeother

Related Parties

1
  • filerCIK 0001941313

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:30 PM ET
Size
31.3 KB